@inproceedings {18273,
	title = {Establishing Guidelines for Obtaining Optimal Cell Sources to Use in Tendon Tissue Engineering Strategies},
	journal = {Tissue Engineering Part A.},
	volume = {20},
	year = {2014},
	month = {2014-12-03 00:00:00},
	pages = {81},
	address = {Washington, DC},
	abstract = {<p style="text-align: justify;"><span>Cell-based approaches in tissue engineering (TE) have been barely explored for the treatment of tendon and ligament (T/L) tissues, requiring the establishment of a widely available cell source with tenogenic potential. As T/L cells are scarce, stem cells may provide a good alternative. Understanding how resident cells behave in vitro, might be useful for recapitulating the tenogenic potential of stem cells for tendon TE applications. Therefore, we propose to isolate and characterize human T/L-derived cells (hTDCs and hLDCs) and compare their regenerative potential with stem cells from adipose tissue (hASCs) and amniotic fluid (hAFSCs)(1).</span></p>},
	keywords = {hAFSCs, hASCs, Tendon TE},
	doi = {10.1089/ten.tea.2014.5000.abstracts},
	author = {Gon{\c c}alves, A. I. and Rodrigues, M. T. and Reis, R. L. and Gomes, M. E.}
}
